마리골드 꽃 생산 및 루테인 공급망 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Marigold Flower Production & Lutein Supply Chain Market was valued at USD 383 million in 2025 and is estimated to grow at a CAGR of 7% to reach USD 752.6 million by 2035.

The market continues to advance because of multiple long-term demand drivers that are reshaping both production and consumption patterns worldwide. Growing elderly populations are increasing demand for nutritional ingredients that support vision health, while prolonged exposure to digital screens is encouraging greater use of eye wellness products across different age groups. Regulatory developments are broadening the approved use of lutein in infant nutrition and functional food applications, creating additional commercial opportunities for manufacturers. At the same time, rising preference for naturally derived food ingredients is accelerating the replacement of synthetic color additives with marigold-derived alternatives. India and China collectively contribute more than 85% of the global raw marigold flower supply, whereas North America and Europe represent the primary markets for high-value processed lutein ingredients, creating a globally connected yet regionally specialized supply chain. Expanding dietary supplement distribution through organized retail channels across Asia Pacific is further supporting regional consumption. The region also combines the world's largest extraction capacity with the fastest-growing demand, reinforcing its position as the primary engine of future market expansion through 2035.

The free lutein (saponified) segment generated USD 107.2 million in 2025, owing to the preferred choice as it offers improved bioavailability compared with ester-based lutein, making it well suited for adult eye health supplement formulations, including softgels and tablets. Strong industry preference for standardized, high-quality free lutein ingredients continues to support widespread adoption across dietary supplement manufacturing, reinforcing the segment's leading position within the overall marigold flower production & lutein supply chain market.

The dietary supplements segment accounted for USD 166.6 million in 2025 and is projected to grow at a 7% CAGR between 2026 and 2035 owing to the extensive scientific research that has strengthened confidence in lutein-based nutritional products. Continuous consumer interest in preventive health, combined with growing awareness of eye wellness, is encouraging consistent demand for lutein-enriched dietary supplements across developed and emerging markets, supporting sustained growth throughout the forecast period.

North America Marigold Flower Production & Lutein Supply Chain Market captured USD 125.6 million in 2025. Regional leadership is supported by the well-established dietary supplement industry in the United States and a stable regulatory environment that encourages ingredient innovation across supplements, food products, and infant nutrition applications. A broad portfolio of commercially available nutritional products, together with consistent consumer demand for health-focused ingredients, continues to create favorable opportunities for ingredient manufacturers operating throughout the regional supply chain.

Major companies operating in the global marigold flower production & lutein supply chain market include Chenguang Biotech Group Co., Ltd. (CCGB), Kemin Industries, Inc., OmniActive Health Technologies, DSM-Firmenich N.V., Zhejiang Medicine Co., Ltd. (ZMC), Divi's Nutraceuticals (Divi's Laboratories Ltd.), Synthite Industries Ltd., AVT Natural Products Ltd., Plant Lipids Pvt. Ltd., Olive Lifesciences Pvt. Ltd., Bio-gen Extracts Pvt. Ltd., Biomax Life Sciences Ltd., Lycored Ltd., Hunan Huakang Biotech Inc., and Aturex Nutritionals. Companies participating in the marigold flower production & lutein supply chain market are strengthening their competitive position by expanding extraction capacity, improving processing efficiency, and investing in advanced purification technologies to enhance product quality and consistency. Many manufacturers are building long-term sourcing relationships with marigold growers to secure reliable raw material availability while reducing supply chain risks. Businesses are also broadening their product portfolios to address demand from dietary supplements, functional foods, infant nutrition, and natural color applications. Strategic geographic expansion, partnerships with ingredient distributors, and stronger regional manufacturing capabilities are helping companies improve market access.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Product form
  • 2.2.2 Purity grade
  • 2.2.3 Application
  • 2.2.4 Supply Chain Stage
  • 2.2.5 Regional
• 2.3 TAM Analysis, 2026-2035
• 2.4 CXO perspectives: Strategic imperatives
• 2.5 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter’s analysis
• 3.6 PESTEL analysis
• 3.7 Technology and innovation landscape
  • 3.7.1 Current technological trends
  • 3.7.2 Emerging technologies
• 3.8 Price trends
  • 3.8.1 By region
  • 3.8.2 By product form
• 3.9 Future market trends
• 3.10 Patent landscape
• 3.11 Trade statistics (HS code)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Form, 2022–2035 (USD Million) (Kilo Tons)

• 5.1 Key trends
• 5.2 Free Lutein (Saponified)
• 5.3 Lutein Ester
• 5.4 Marigold Oleoresin
• 5.5 Lutein Beadlets
• 5.6 Lutein Powder/Crystalline
• 5.7 Lutein Oil Suspension

Chapter 6 Market Estimates and Forecast, By Purity Grade, 2022–2035 (USD Million) (Kilo Tons)

• 6.1 Key trends
• 6.2 Standard Grade (5%–50% Lutein Purity)
• 6.3 High Purity Grade (≥80% Lutein Purity)
• 6.4 Food Grade (50%–79% Lutein Purity)

Chapter 7 Market Estimates and Forecast, By Application, 2022–2035 (USD Million) (Kilo Tons)

• 7.1 Key trends
• 7.2 Dietary Supplements
• 7.3 Food & Beverages
• 7.4 Animal Feed
• 7.5 Pharmaceuticals
• 7.6 Cosmetics & Personal Care
• 7.7 Others

Chapter 8 Market Estimates and Forecast, By Supply Chain Stage, 2022–2035 (USD Million) (Kilo Tons)

• 8.1 Key trends
• 8.2 Midstream (Extraction & Processing)
• 8.3 Downstream (Formulation & Distribution)
• 8.4 Upstream (Cultivation & Harvesting)

Chapter 9 Market Estimates and Forecast, By Region, 2022–2035 (USD Million) (Kilo Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Chenguang Biotech Group Co., Ltd. (CCGB)
• 10.2 Kemin Industries, Inc.
• 10.3 OmniActive Health Technologies
• 10.4 DSM-Firmenich N.V.
• 10.5 Zhejiang Medicine Co., Ltd. (ZMC)
• 10.6 Divi's Nutraceuticals (Divi's Laboratories Ltd.)
• 10.7 Synthite Industries Ltd.
• 10.8 AVT Natural Products Ltd.
• 10.9 Plant Lipids Pvt. Ltd.
• 10.10 Olive Lifesciences Pvt. Ltd.
• 10.11 Bio-gen Extracts Pvt. Ltd.
• 10.12 Biomax Life Sciences Ltd.
• 10.13 Lycored Ltd.
• 10.14 Hunan Huakang Biotech Inc.
• 10.15 Aturex Nutritionals